All Stories

  1. Resin-Modified Calcium Silicate-Based Materials Versus Conventional Formulations in Primary Teeth: A Systematic Review and Meta-Analysis of Clinical and Radiographic Outcomes of Vital Pulp Therapy Procedures in Pediatric Dentistry
  2. Emerging Role of MDSCS as Novel Biomarkers and Therapeutic Targets for Cancer Immunotherapy
  3. Ketone Bodies Are Potential Prognostic Biomarkers in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results from the R2-GDP-GOTEL Trial
  4. Neutropenia and Felty Syndrome in the Twenty-First Century: Redefining Ancient Concepts in Rheumatoid Arthritis Patients
  5. Experience Using a New High-Density Polyethylene-Based Porous Orbital Implant: Explorative 1-Year Performance and Safety Results
  6. Long-Term Mental Health after High-Density Polyethylene-Based Porous Orbital Implant in Enucleated and Eviscerated Patients
  7. Role of Nutrients Regulating Myeloid Derived Suppressor Cells in Cancer: A Scoping Review
  8. The Expression of Genes Related to Reverse Cholesterol Transport and Leptin Receptor Pathways in Peripheral Blood Mononuclear Cells Are Decreased in Morbid Obesity and Related to Liver Function
  9. Influence of the Surface Topography of Titanium Dental Implants on the Behavior of Human Amniotic Stem Cells
  10. Role of Leptin in Obesity, Cardiovascular Disease, and Type 2 Diabetes
  11. Cancer Nano-Immunotherapy: The Novel and Promising Weapon to Fight Cancer
  12. Tissue-specific Activated Regulatory Lymphocytes Immunophenotype in Chronic Rhinosinusitis with Nasal Polyps
  13. Defining the Emergence of New Immunotherapy Approaches in Breast Cancer: Role of Myeloid-Derived Suppressor Cells
  14. Role of Leptin as a Link between Asthma and Obesity: A Systematic Review and Meta-Analysis
  15. Obesity and Risk for Lymphoma: Possible Role of Leptin
  16. Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study
  17. The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells
  18. Ewing Sarcoma Meets Epigenetics, Immunology and Nanomedicine: Moving Forward into Novel Therapeutic Strategies
  19. Decreased Expression of Sam68 Is Associated with Insulin Resistance in Granulosa Cells from PCOS Patients
  20. Obesity as a Risk Factor for Dementia and Alzheimer’s Disease: The Role of Leptin
  21. Tumor Immune Microenvironment in Lymphoma: Focus on Epigenetics
  22. Leptin in Dental Pulp and Periapical Tissues: A Narrative Review
  23. Nutrients and Dietary Approaches in Patients with Type 2 Diabetes Mellitus and Cardiovascular Disease: A Narrative Review
  24. Possible Role of Leptin in Atopic Dermatitis: A Literature Review
  25. Increased Blood Monocytic Myeloid Derived Suppressor Cells but Low Regulatory T Lymphocytes in Patients with Mild COVID-19
  26. Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
  27. Lower Survival and Increased Circulating Suppressor Cells in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma with Deficit of Vitamin D Levels Using R-GDP Plus Lenalidomide (R2-GDP): Results from the R2-GDP-GOTEL Trial
  28. Publisher Correction: Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
  29. Circulating immune biomarkers in peripheral blood correlate with clinical outcomes in advanced breast cancer
  30. Role of Leptin in Non-Alcoholic Fatty Liver Disease
  31. Leptin, Both Bad and Good Actor in Cancer
  32. Role of Leptin in Inflammation and Vice Versa
  33. Leptin and Nutrition in Gestational Diabetes
  34. Leptin and Gestational Diabetes Mellitus
  35. Postprandial triglyceride-rich lipoproteins promote M1/M2 microglia polarization in a fatty-acid-dependent manner
  36. Aquaporins and placenta
  37. Maternal diet modulates placental nutrient transporter gene expression in a mouse model of diabetic pregnancy
  38. Screening for Gestational Diabetes Mellitus by Measuring Glycated Hemoglobin Can Reduce the Use of the Glucose Challenge Test
  39. Automated urinalysis combining physicochemical analysis, on-board centrifugation, and digital imaging in one system: A multicenter performance evaluation of the cobas 6500 urine work area
  40. Pitfalls of ABO Genotyping Based on Targeted Single Nucleotide Variant Analysis Due to a Nondeletional O Allele Lacking c.261delG: First Report of ABO*O.09.01 in Korea
  41. Human amniotic membrane conditioned medium inhibits proliferation and modulates related microRNAs expression in hepatocarcinoma cells
  42. ROLE OF LEPTIN ON THE APOPTOSIS OF TROPHOBLAST EXPLANTS TRIGGERED BY ACIDOSIS
  43. Obesity and Breast Cancer: Role of Leptin
  44. Myeloid derived-suppressor cells in healthy women and in advanced breast cancer patients
  45. First-trimester proteomic profiling identifies novel predictors of gestational diabetes mellitus
  46. Circulating regulatory T cells from breast cancer patients in response to neoadjuvant chemotherapy
  47. Leptin stimulates DMP-1 and DSPP expression in human dental pulp via MAPK 1/3 and PI3K signaling pathways
  48. Leptin protects placental cells from apoptosis induced by acidic stress
  49. New horizons in breast cancer: the promise of immunotherapy
  50. Diabetes mellitus y riesgo cardiovascular. Actualización de las recomendaciones del Grupo de Trabajo de Diabetes y Riesgo Cardiovascular de la Sociedad Española de Diabetes (SED, 2018)
  51. Placental leptin expression is mediated by NFκB signaling
  52. Proliferation and survival of human amniotic epithelial cells during their hepatic differentiation
  53. Fasting Glycemia as Screening Tool to Rule-Out Gestational Diabetes in Low-Risk Population
  54. Leptin action in normal and pathological pregnancies
  55. Involvement of leptin in the molecular physiology of the placenta
  56. Leptin upregulates aquaporin 9 expression in human placenta in vitro
  57. Human amniotic epithelial cells: evaluation of survival during their hepatic differentiation
  58. Transcription factors involved in estradiol leptin induction in placenta
  59. Sp1 transcription factor is a modulator of estradiol leptin induction in placental cells
  60. The impact of systems-of-care on pharmacoinvasive management with streptokinase: The subgroup analysis of the TN-STEMI programme
  61. MgO-based adsorbents for CO2 adsorption: Influence of structural and textural properties on the CO2 adsorption performance
  62. Role of leptin as a link between metabolism and the immune system
  63. Inhibition of HMGB1 protects the retina from ischemia-reperfusion, as well as reduces insulin resistance proteins
  64. A System of Care for Patients With ST-Segment Elevation Myocardial Infarction in India
  65. Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India
  66. Amniotic membrane conditioned medium promotes cell death and inhibits proliferation of hepatocarcinoma HepG2 cells
  67. Role of leptin in the molecular physiology of the placenta
  68. Action and Mechanisms of Action of the Chromogranin A Derived Peptide Pancreastatin
  69. Breast Cancer Immunology and Immunotherapy
  70. Comparison of Citrate Buffer with Sodium Fluoride as Additives in Determining Glycemia
  71. Pancreastatin Signaling. Mechanisms of Action ☆
  72. Pancreastatin, a Regulatory Peptide Derived From Chromogranin A ☆
  73. Prevalence of parameters of suboptimal scaffold deployment following angiographic guided bioresorbable vascular scaffold implantation in real world practice - an optical coherence tomography analysis
  74. A case of recurrent unstable angina – Insight from optical coherence tomography imaging
  75. Sam68 Mediates the Activation of Insulin and Leptin Signalling in Breast Cancer Cells
  76. Leptin reduces apoptosis triggered by high temperature in human placental villous explants: The role of the p53 pathway
  77. Diabetes mellitus y riesgo cardiovascular: recomendaciones del Grupo de Trabajo Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED, 2015)
  78. Increased Expression of Aquaporin 9 in Trophoblast From Gestational Diabetic Patients
  79. Risk Factors for Hyperglycaemia in Pregnancy in Tamil Nadu, India
  80. Two-year follow-up data from the STEPP-AMI study: A prospective, observational, multicenter study comparing tenecteplase-facilitated PCI versus primary PCI in Indian patients with STEMI
  81. Insulin and Leptin Signaling in Placenta from Gestational Diabetic Subjects
  82. Mechanisms involved in p53 downregulation by leptin in trophoblastic cells
  83. Framework for a National STEMI Program: Consensus document developed by STEMI INDIA, Cardiological Society of India and Association Physicians of India
  84. Aortic Stiffness and Cardiovascular Risk in Women with Previous Gestational Diabetes Mellitus
  85. Diabetes mellitus y riesgo cardiovascular: recomendaciones del Grupo de Trabajo Diabetes y Enfermedad Cardiovascular de la Sociedad Española de Diabetes (SED, 2015)
  86. Evaluation of a HbA1c point-of-care analyzer
  87. Association between Obesity Indices and Insulin Resistance among Healthy Korean Adolescents: The JS High School Study
  88. Evaluation of the Nova StatSensor® XpressTM Creatinine Point-Of-Care Handheld Analyzer
  89. Testing Pancreatic Islet Function at the Single Cell Level by Calcium Influx with Associated Marker Expression
  90. Protective effect of leptin on the apoptosis of trophoblast explants triggered by high temperature
  91. Antiapoptotic effects of leptin on trophoblasts
  92. Human amniotic epithelial cells: Proliferation and apoptosis during their hepatic differentiation
  93. Leptin is involved in human trophoblast migration and invasion
  94. Role of Sam68 in leptin and insulin signaling in granulosa cells
  95. Leptin promotes HLA-G expression on placental trophoblasts via the MEK/Erk and PI3K signaling pathways
  96. Leptin Promotes Dentin Sialophosphoprotein Expression in Human Dental Pulp
  97. Role of leptin in female reproduction
  98. Expression and immunohistochemical localization of leptin in human periapical granulomas
  99. GSK3β Is Increased in Adipose Tissue and Skeletal Muscle from Women with Gestational Diabetes Where It Regulates the Inflammatory Response
  100. Reference Intervals for N-Terminal Pro-B-Type Natriuretic Peptide in Amniotic Fluid between 10 and 34 Weeks of Gestation
  101. Leptin Downregulates Aggrecan through the p38-ADAMST Pathway in Human Nucleus Pulposus Cells
  102. Expression and immunohistochemical localization of leptin receptor in human periapical granuloma
  103. Pathological Complete Response and Changes Related to T Infiltrating Lymphocytes and Regulatory T Cells in Tissue and Peripheral Blood After Neoadjuvant Chemotherapy in Breast Carcinoma
  104. Leptin Is an Anti-Apoptotic Effector in Placental Cells Involving p53 Downregulation
  105. Correction: CD69 Is a TGF-β/1α,25-dihydroxyvitamin D3Target Gene in Monocytes
  106. Leptin Receptor Is Up-regulated in Inflamed Human Dental Pulp
  107. Role of Sam68 in Post-Transcriptional Gene Regulation
  108. Adiponectin Impairs Chicken Preadipocytes Differentiation through p38 MAPK/ATF-2 and TOR/p70 S6 Kinase Pathways
  109. Effective treatment of pulmonary tuberculosis restores plasma leptin levels
  110. Altered Regulation of ELAVL1/HuR in HLA-B27–Expressing U937 Monocytic Cells
  111. Insulin Enhances Leptin Expression in Human Trophoblastic Cells1
  112. CD69 Is a TGF-β/1α,25-dihydroxyvitamin D3 Target Gene in Monocytes
  113. Activated Translation Signaling in Placenta from Pregnant Women with Gestational Diabetes Mellitus: Possible Role of Leptin
  114. New Insights into the Role of the Immune Microenvironment in Breast Carcinoma
  115. The Role of Insulin C-Peptide in the Coevolution Analyses of the Insulin Signaling Pathway: A Hint for Its Functions
  116. Leptin expression in healthy and inflamed human dental pulp
  117. The Alternative Epac/cAMP Pathway and the MAPK Pathway Mediate hCG Induction of Leptin in Placental Cells
  118. Correction: Exogenous Amino Acids Are Essential for Interleukin-7 Induced CD8 T Cell Gowth
  119. Increased Autophagy in Placentas of Intrauterine Growth-Restricted Pregnancies
  120. A Two-Step Screening, Measurement of HbA1c in Association with FPG, May Be Useful in Predicting Diabetes
  121. Exogenous Amino Acids Are Essential for Interleukin-7 Induced CD8 T Cell Gowth
  122. Regulation of leptin expression by 17beta-estradiol in human placental cells involves membrane associated estrogen receptor alpha
  123. Elsevier Trophoblast Research Award Lecture: Molecular mechanisms underlying estrogen functions in trophoblastic cells − Focus on leptin expression
  124. Sam68 interacts with IRS1
  125. Sam68 mediates leptin-stimulated growth by modulating leptin receptor signaling in human trophoblastic JEG-3 cells
  126. Review: Leptin gene expression in the placenta – Regulation of a key hormone in trophoblast proliferation and survival
  127. Evaluation of two HbA1c point-of-care analyzers
  128. Leptin receptor activation increases Sam68 tyrosine phosphorylation and expression in human trophoblastic cells
  129. Reprint of: Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin
  130. Glycated hemoglobin vs. the oral glucose tolerance test for the exclusion of impaired glucose tolerance in high-risk individuals
  131. Regulation of Placental Leptin Expression by Cyclic Adenosine 5′-Monophosphate Involves Cross Talk between Protein Kinase A and Mitogen-Activated Protein Kinase Signaling Pathways
  132. 17Beta-Estradiol Enhances Leptin Expression in Human Placental Cells Through Genomic and Nongenomic Actions1
  133. MAPK and PI3K activities are required for leptin stimulation of protein synthesis in human trophoblastic cells
  134. Blocking of melatonin synthesis and MT1 receptor impairs the activation of Jurkat T cells
  135. Metabolic effects and mechanism of action of the chromogranin A-derived peptide pancreastatin
  136. Role of Leptin in the Activation of Immune Cells
  137. Leptin Stimulates Protein Synthesis-Activating Translation Machinery in Human Trophoblastic Cells1
  138. Oleoylethanolamide, a natural ligand for PPAR-alpha, inhibits insulin receptor signalling in HTC rat hepatoma cells
  139. P-62: Role of phosphatidylinositol-3-kinase and S6 kinase in insulin-stimulated glycogen synthesis
  140. P-78: Role of p85 isoforms of phosphatidylinositol-3-kinase in insulin receptor signaling
  141. Up-Regulation of Placental Leptin by Human Chorionic Gonadotropin
  142. Role of Leptin in the Immune System
  143. Leptin prevents apoptosis of trophoblastic cells by activation of MAPK pathway
  144. Use of Point-of-Care-Testing Glucose Meters in the Oral Glucose Tolerant Test
  145. Profile of Patients Triply Infected with HIV and the Hepatitis B and C Viruses in the HAART Era
  146. Resultados de la implantación de un sistema de control de calidad para los glucómetros del Área Hospitalaria Virgen Macarena, con conexión on-line al Laboratorio de Bioquímica Clínica, durante el período 2003–2007,
  147. Leptin promotes cell survival and activates Jurkat T lymphocytes by stimulation of mitogen-activated protein kinase
  148. Leptin Promotes Cell Proliferation and Survival of Trophoblastic Cells1
  149. Regulation of the Immune Response by Leptin
  150. Signalling mechanisms regulating lipolysis
  151. Hyperhomocysteinemia correlates with insulin resistance and low-grade systemic inflammation in obese prepubertal children
  152. Pancreastatin: Multiple Actions on Human Intermediary Metabolismin Vivo, Variation in Disease, and Naturally Occurring Functional Genetic Polymorphism
  153. Sam68 is tyrosine phosphorylated and recruited to signalling in peripheral blood mononuclear cells from HIV infected patients
  154. Oleylethanolamide impairs glucose tolerance and inhibits insulin-stimulated glucose uptake in rat adipocytes through p38 and JNK MAPK pathways
  155. Homocysteine thiolactone inhibits insulin-stimulated DNA and protein synthesis: possible role of mitogen-activated protein kinase (MAPK), glycogen synthase kinase-3 (GSK-3) and p70 S6K phosphorylation
  156. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells
  157. Educational intervention together with an on-line quality control program achieve recommended analytical goals for bedside blood glucose monitoring in a 1200-bed university hospital
  158. Role of Sam68 as an adaptor protein in signal transduction
  159. Pancreastatin, A Regulatory Peptide that Modulates Energy Metabolism
  160. Marcadores biológicos de inflamación vascular y aterosclerosis subclínica en el síndrome metabólico
  161. Marcadores biológicos de inflamación vascular y aterosclerosis subclínica en el síndrome metabólico
  162. Expression of activation molecules in neutrophils, monocytes and lymphocytes from patients with unstable angina treated with stent implantation
  163. Pancreastatin, a chromogranin A-derived peptide, inhibits leptin and enhances UCP-2 expression in isolated rat adipocytes
  164. Leptin stimulates the oxidative burst in control monocytes but attenuates the oxidative burst in monocytes from HIV-infected patients
  165. Role of leptin as an immunomodulator of blood mononuclear cells: mechanisms of action
  166. The expression of Sam68, a protein involved in insulin signal transduction, is enhanced by insulin stimulation
  167. Pancreastatin
  168. Pancreastatin Receptor Signaling
  169. Human leptin promotes survival of human circulating blood monocytes prone to apoptosis by activation of p42/44 MAPK pathway
  170. Pancreastatin, a chromogranin A-derived peptide, activates protein synthesis signaling cascade in rat adipocytes
  171. Leptin receptor (Ob-R) expression is induced in peripheral blood mononuclear cells byin vitroactivation andin vivoin HIV-infected patients
  172. Elevated plasma total homocysteine levels in hyperinsulinemic obese subjects
  173. Inflammatory Response to Coronary Stent Implantation in Patients with Unstable Angina
  174. Differential expression of a WD protein during squamous differentiation of tracheal epithelial cells
  175. Sam68 associates with the SH3 domains of Grb2 recruiting GAP to the Grb2‐SOS complex in insulin receptor signaling
  176. Pancreastatin, a Chromogranin-A-Derived Peptide, Inhibits Insulin-Stimulated Glycogen Synthesis by Activating GSK-3 in Rat Adipocytes
  177. Sam68 is a docking protein linking GAP and PI3K in insulin receptor signaling
  178. Human Leptin Activates PI3K and MAPK Pathways in Human Peripheral Blood Mononuclear Cells: Possible Role of Sam68
  179. Homocysteine thiolactone inhibits insulin signaling, and glutathione has a protective effect
  180. Pancreastatin, a chromogranin A-derived peptide, inhibits DNA and protein synthesis by producing nitric oxide in HTC rat hepatoma cells
  181. Human Leptin Signaling in Human Peripheral Blood Mononuclear Cells: Activation of the JAK-STAT Pathway
  182. Pancreastatin, a chromogranin A-derived peptide, activates Gα16 and phospholipase C-β2 by interacting with specific receptors in rat heart membranes
  183. Pancreastatin modulates insulin signaling in rat adipocytes: mechanisms of cross-talk.
  184. Characterization of pancreastatin receptor and signaling in rat HTC hepatoma cells
  185. Affinity Purification of Pancreastatin Receptor–Gq/11 Protein Complex from Rat Liver Membranes
  186. Stimulation of glycogen synthesis by insulin requires S6 kinase and phosphatidylinositol-3-kinase in HTC-IR cells
  187. Human Leptin Enhances Activation and Proliferation of Human Circulating T Lymphocytes
  188. Characterization of pancreastatin receptors and signaling in adipocyte membranes
  189. p68 Sam is a substrate of the insulin receptor and associates with the SH2 domains of p85 PI3K
  190. G protein Gαq11 and Gαi1,2 are activated by pancreastatin receptors in rat liver: Studies with GTP‐γ35S and azido‐GTP‐α‐32P
  191. Human Leptin Stimulates Proliferation and Activation of Human Circulating Monocytes
  192. Modulation of insulin receptor signalling by pancreastatin in HTC hepatoma cells
  193. Insulin activates Gαil,2 protein in rat hepatoma (HTC) cell membranes
  194. Pancreastatin inhibits insulin action in rat adipocytes
  195. Increased plasma pancreastatin-like levels in gestational diabetes: correlation with catecholamine levels.
  196. Pancreastatin activates β3 isoform of phospholipase C via Gα11 protein stimulation in rat liver membranes
  197. Pancreastatin receptor is coupled to a guanosine triphosphate-binding protein of the Gg/11α family in rat liver membranes
  198. Normal pancreastatin-like and increased post-glucose insulin levels in young offspring of insulin-resistant non-obese essential hypertensive patients
  199. Solubilization and Molecular Characterization of Active Pancreastatin Receptors from Rat Liver Membranes1
  200. Solubilization and Molecular Characterization of Active Pancreastatin Receptors from Rat Liver Membranes
  201. Pancreastatin Signaling in the Liver
  202. Pancreastatin: further evidence for its consideration as a regulatory peptide
  203. Pancreastatin action in the liver: Dual coupling to different G proteins
  204. A Chemiluminescence Method to Analyze Phosphatidylcholine–Phospholipase Activity in Plasma Membrane Preparations and in Intact Cells
  205. Protein kinase C involvement in apoptosis
  206. Plasma pancreastatin-like immunoreactivity correlates with plasma norepinephrine levels in essential hypertension
  207. Role of p85 subunit of phosphatidylinositol-3-kinase as an adaptor molecule linking the insulin receptor to insulin receptor substrate 1
  208. Insulin-like growth factor-1 stimulation of cells induces formation of complexes containing phosphatidylinositol-3-kinase, guanosine triphosphatase-activating protein (GAP), and p62 GAP-associated protein.
  209. Pancreastatin activates protein kinase C by stimulating the formation of 1,2-diacylglycerol in rat hepatocytes
  210. Role of Phosphatidylinositol-3-Kinase in Insulin Receptor Signaling: Studies with Inhibitor, LY294002
  211. Pancreastatin activates pertussis toxin‐sensitive guanylate cyclase and pertussis toxin‐insensitive phospholipase C in rat liver membranes
  212. Pancreastatin inhibits insulin-stimulated glycogen synthesis but not glycolysis in rat hepatocytes
  213. Protein kinase C activation promotes cell survival in mature lymphocytes prone to apoptosis
  214. Sensitivity of Insulin-Secreting RIN m5F Cells to Undergoing Apoptosis by the Protein Kinase C Inhibitor Staurosporine
  215. Pancreastatin increases free cytosolic Ca2+ in rat hepatocytes, involving both pertussis-toxin-sensitive and -insensitive mechanisms
  216. Pancreastatin (33–49) enhances the priming effect of glucose in the rat pancreas
  217. Pancreastatin decreases plasma epinephrine levels in surgical stress in the rat
  218. Pancreastatin increases cytosolic Ca2+ in insulin secreting RINm5F cells
  219. Pancreastatin and its 33–49 C-terminal fragment inhibit glucagon-stimulated insulin in vivo
  220. Glycogenolytic effect of pancreastatin in isolated rat hepatocytes is mediated by a cyclic-AMP-independent Ca2+-dependent mechanism
  221. Decreased protein kinase C activity is associated with programmed cell death (apoptosis) in freshly isolated rat hepatocytes
  222. Glycogenolytic effect of vasoactive intestinal peptide in the rat in vivo
  223. Glycogenolytic effect of pancreastatin in the rat
  224. Pancreastatin
  225. Pancreastatin
  226. Purification of Pancreastatin Receptor from Rat Liver Membranes